These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 27810556

  • 1. Transporter occluded-state conformation-induced endocytosis: Amino acid transporter ATB0,+-mediated tumor targeting of liposomes for docetaxel delivery for hepatocarcinoma therapy.
    Luo Q, Gong P, Sun M, Kou L, Ganapathy V, Jing Y, He Z, Sun J.
    J Control Release; 2016 Dec 10; 243():370-380. PubMed ID: 27810556
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The anti-tumor performance of docetaxel liposomes surface-modified with glycyrrhetinic acid.
    Li J, Xu H, Ke X, Tian J.
    J Drug Target; 2012 Jun 10; 20(5):467-73. PubMed ID: 22577855
    [Abstract] [Full Text] [Related]

  • 4. Endocytosis of ATB0,+(SLC6A14)-targeted liposomes for drug delivery and its therapeutic application for pancreatic cancer.
    Kou L, Huang H, Lin X, Jiang X, Wang Y, Luo Q, Sun J, Yao Q, Ganapathy V, Chen R.
    Expert Opin Drug Deliv; 2020 Mar 10; 17(3):395-405. PubMed ID: 31990587
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma.
    Wei M, Guo X, Tu L, Zou Q, Li Q, Tang C, Chen B, Xu Y, Wu C.
    Int J Nanomedicine; 2015 Mar 10; 10():5123-37. PubMed ID: 26316745
    [Abstract] [Full Text] [Related]

  • 11. Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer.
    Patel K, Doddapaneni R, Sekar V, Chowdhury N, Singh M.
    Mol Pharm; 2016 Jun 06; 13(6):2049-58. PubMed ID: 27070720
    [Abstract] [Full Text] [Related]

  • 12. Effect of a controlled-release drug delivery system made of oleanolic acid formulated into multivesicular liposomes on hepatocellular carcinoma in vitro and in vivo.
    Luo Y, Liu Z, Zhang X, Huang J, Yu X, Li J, Xiong D, Sun X, Zhong Z.
    Int J Nanomedicine; 2016 Jun 06; 11():3111-29. PubMed ID: 27471381
    [Abstract] [Full Text] [Related]

  • 13. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles.
    Liu Q, Li R, Zhu Z, Qian X, Guan W, Yu L, Yang M, Jiang X, Liu B.
    Int J Pharm; 2012 Jul 01; 430(1-2):350-8. PubMed ID: 22525076
    [Abstract] [Full Text] [Related]

  • 14. In Vitro and In Vivo Evaluation of SP94 Modified Liposomes Loaded with N-14NCTDA, a Norcantharimide Derivative for Hepatocellular Carcinoma-Targeting.
    Jiang Y, Liu X, Tan X, Hou Y, Sun W, Gou J, Yin T, He H, Zhang Y, Tang X.
    AAPS PharmSciTech; 2020 Oct 08; 21(7):277. PubMed ID: 33033942
    [Abstract] [Full Text] [Related]

  • 15. Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting.
    Tiantian Y, Wenji Z, Mingshuang S, Rui Y, Shuangshuang S, Yuling M, Jianhua Y, Xinggang Y, Shujun W, Weisan P.
    Int J Pharm; 2014 Aug 25; 471(1-2):245-57. PubMed ID: 24858386
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Eph A10-modified pH-sensitive liposomes loaded with novel triphenylphosphine-docetaxel conjugate possess hierarchical targetability and sufficient antitumor effect both in vitro and in vivo.
    Zhang J, Yang C, Pan S, Shi M, Li J, Hu H, Qiao M, Chen D, Zhao X.
    Drug Deliv; 2018 Nov 25; 25(1):723-737. PubMed ID: 29513049
    [Abstract] [Full Text] [Related]

  • 18. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect.
    Xie Q, Deng W, Yuan X, Wang H, Ma Z, Wu B, Zhang X.
    Eur J Pharm Biopharm; 2018 Jan 25; 122():87-95. PubMed ID: 29032193
    [Abstract] [Full Text] [Related]

  • 19. A novel lactoferrin-modified stealth liposome for hepatoma-delivery of triiodothyronine.
    Pireddu R, Pibiri M, Valenti D, Sinico C, Fadda AM, Simbula G, Lai F.
    Int J Pharm; 2018 Feb 15; 537(1-2):257-267. PubMed ID: 29294323
    [Abstract] [Full Text] [Related]

  • 20. Large amino acid transporter 1 mediated glutamate modified docetaxel-loaded liposomes for glioma targeting.
    Li L, Di X, Zhang S, Kan Q, Liu H, Lu T, Wang Y, Fu Q, Sun J, He Z.
    Colloids Surf B Biointerfaces; 2016 May 01; 141():260-267. PubMed ID: 26859117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.